106 related articles for article (PubMed ID: 3752956)
1. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
Ho DH; Townsend L; Luna MA; Bodey GP
Anticancer Res; 1986; 6(4):781-4. PubMed ID: 3752956
[TBL] [Abstract][Full Text] [Related]
2. Enzymes of uracil catabolism in normal and neoplastic human tissues.
Naguib FN; el Kouni MH; Cha S
Cancer Res; 1985 Nov; 45(11 Pt 1):5405-12. PubMed ID: 3931905
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.
Tatsumi K; Fukushima M; Shirasaka T; Fujii S
Jpn J Cancer Res; 1987 Jul; 78(7):748-55. PubMed ID: 3114201
[TBL] [Abstract][Full Text] [Related]
4. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
[TBL] [Abstract][Full Text] [Related]
6. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
Naguib FN; Hao SN; el Kouni MH
Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135
[TBL] [Abstract][Full Text] [Related]
8. Effect of 5-diazouracil on the catabolism of circulating pyrimidines in rat liver and kidneys.
Holstege A; Pausch J; Gerok W
Cancer Res; 1986 Nov; 46(11):5576-81. PubMed ID: 3756903
[TBL] [Abstract][Full Text] [Related]
9. Catabolism of exogenously supplied thymidine to thymine and dihydrothymine by platelets in human peripheral blood.
Pero RW; Johnson D; Olsson A
Cancer Res; 1984 Nov; 44(11):4955-61. PubMed ID: 6488159
[TBL] [Abstract][Full Text] [Related]
10. Behavior of activities of thymidine metabolizing enzymes in human leukemia-lymphoma cells.
Shiotani T; Hashimoto Y; Tanaka T; Irino S
Cancer Res; 1989 Mar; 49(5):1090-4. PubMed ID: 2917346
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
[TBL] [Abstract][Full Text] [Related]
12. 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase.
Tatsumi K; Yamauchi T; Kiyono K; Kishi K; Yanagihara Y; Imaoka T; Kawaguchi T; Kubo M
J Biochem; 1993 Dec; 114(6):912-8. PubMed ID: 8138551
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidine dehydrogenase in livers from mouse and rat, and in human liver, colon tumors, and mucosa in relation to anabolism of 5-fluorouracil.
Peters GJ; van Groeningen CJ; Pinedo HM
Adv Exp Med Biol; 1998; 431():633-6. PubMed ID: 9598142
[No Abstract] [Full Text] [Related]
14. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
[TBL] [Abstract][Full Text] [Related]
15. Purification and properties of dihydrothymine dehydrogenase from rat liver.
Shiotani T; Weber G
J Biol Chem; 1981 Jan; 256(1):219-24. PubMed ID: 7451435
[TBL] [Abstract][Full Text] [Related]
16. Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines.
Naguib FN; Soong SJ; el Kouni MH
Biochem Pharmacol; 1993 Feb; 45(3):667-73. PubMed ID: 8442766
[TBL] [Abstract][Full Text] [Related]
17. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
[TBL] [Abstract][Full Text] [Related]
18. Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase.
Goudgaon NM; Naguib FN; el Kouni MH; Schinazi RF
J Med Chem; 1993 Dec; 36(26):4250-4. PubMed ID: 8277507
[TBL] [Abstract][Full Text] [Related]
19. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
20. [Interactions between UFT and anticoagulants].
Ogawa J; Inoue H; Shohtsu A
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):790. PubMed ID: 3114615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
